Defunct Company
Total Trials
6
As Lead Sponsor
4
As Collaborator
2
Total Enrollment
312
NCT00964262
A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 31, 2009
Completion: Oct 31, 2010
NCT01507038
Safety and Efficacy of YH14617 in Diabetes Mellitus
Phase: Phase 2
Role: Collaborator
Start: Dec 31, 2011
Completion: Feb 28, 2015
NCT04269642
SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Disease
Start: Mar 19, 2020
Completion: Dec 31, 2021
NCT04621149
An Outpatient Study Investigating Non-prescription Treatments for COVID-19
Start: Nov 15, 2020
Completion: Mar 31, 2022
NCT04783636
To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers
Start: Mar 11, 2021
Completion: Jul 20, 2021
NCT05196204
Trunk Task-oriented Training Combined With Functional Electrical Stimulation in Spinal Cord Injured Individuals
Phase: N/A
Start: May 11, 2021
Completion: Oct 31, 2022